Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -2404.23% is 47% above its 4-year average of -4532.43%, near the high end of its 4-year range (-329100.00%–-1247.78%).
2.18% above its 12-month average of -2457.75%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2026 (2026-06-30): -1618.51%.
EBITDA MARGIN
-2404.23%
EBITDA MARGIN AVG TTM
-2457.75%
EBITDA MARGIN AVG 3Y
-4019.03%
EBITDA MARGIN AVG 5Y
-4532.43%
EBITDA MARGIN AVG 10Y
-4518.97%
EBITDA MARGIN AVG 15Y
-3830.34%
EBITDA MARGIN AVG 20Y
-3437.05%
CURRENT VS TTM AVG
+2.18%
CURRENT VS 3Y AVG
+40.18%
CURRENT VS 5Y AVG
+46.95%
CURRENT VS 10Y AVG
+46.80%
CURRENT VS 15Y AVG
+37.23%
CURRENT VS 20Y AVG
+30.05%
Pluri Inc.
Market Cap
$10.59M
EBITDA Margin
-2404.23%
TTM Avg
-2457.75%
3Y Avg
-4019.03%
5Y Avg
-4532.43%
Market Cap
$10.59M
EBITDA Margin
-778.88%
TTM Avg
-678.54%
3Y Avg
-485.57%
5Y Avg
-387.51%
Market Cap
$10.56M
EBITDA Margin
-10625.29%
TTM Avg
-6424.40%
3Y Avg
-6424.40%
5Y Avg
-6424.40%
Market Cap
$10.52M
EBITDA Margin
-75.15%
TTM Avg
-68.19%
3Y Avg
-159.10%
5Y Avg
-185.14%
Market Cap
$10.84M
EBITDA Margin
-284.92%
TTM Avg
-261.31%
3Y Avg
-2315.78%
5Y Avg
-2461.07%
Market Cap
$10.51M
EBITDA Margin
-1346.05%
TTM Avg
-2835.20%
3Y Avg
-1619.25%
5Y Avg
-1619.25%
Market Cap
$10.37M
EBITDA Margin
-2995.72%
TTM Avg
-2995.72%
3Y Avg
-2995.72%
5Y Avg
-2995.72%
Market Cap
$10.30M
EBITDA Margin
-273136.36%
TTM Avg
-273136.36%
3Y Avg
-93106.62%
5Y Avg
-57343.52%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pluri Inc. (PLUR) | $10.59M | -2404.23% | -2457.75% | -4019.03% | -4532.43% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.59M | -778.88% | -678.54% | -485.57% | -387.51% |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | N/A | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | -10625.29% | -6424.40% | -6424.40% | -6424.40% |
| Lifeward Ltd. (LFWD)vs › | $10.52M | -75.15% | -68.19% | -159.10% | -185.14% |
| Cerenome, Inc. (CNSY)vs › | $10.84M | -284.92% | -261.31% | -2315.78% | -2461.07% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | -1346.05% | -2835.20% | -1619.25% | -1619.25% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.37M | -2995.72% | -2995.72% | -2995.72% | -2995.72% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.30M | -273136.36% | -273136.36% | -93106.62% | -57343.52% |
| Caring Brands, Inc. (CABR)vs › | $10.91M | -133689.80% | -133689.80% | -133689.80% | -133689.80% |
Gross Margin
44.6%
EBITDA Margin
-2404.2%
Operating Margin
-2455.9%
Net Margin
-2406.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -1618.51% |
| 2026-03-31 | -3845.51% |
| 2025-12-31 | -3220.71% |
| 2025-09-30 | -1968.35% |
| 2025-06-30 | -1635.68% |
| 2025-03-31 | -1247.78% |
| 2024-12-31 | -2642.70% |
| 2024-09-30 | -1574.54% |
| 2024-06-30 | -6221.88% |
| 2024-03-31 | -7708.45% |
| 2023-12-31 | -4903.81% |
| 2023-09-30 | -9833.33% |
| 2023-06-30 | -5826.13% |
| 2023-03-31 | -8059.77% |
| 2022-12-31 | -329100.00% |
| 2022-09-30 | -7842.53% |
| 2022-03-31 | -4369.23% |
| 2019-12-31 | -26013.04% |
| 2019-06-30 | -36.17% |
| 2018-12-31 | -15666.00% |
| 2018-09-30 | -211675.00% |
| 2018-06-30 | 1605.83% |
| 2017-12-31 | -15918.00% |
| 2017-09-30 | -1344.66% |
| 2017-06-30 | -20.36% |
| 2016-06-30 | -37.95% |
| 2015-12-31 | -134.23% |
| 2015-09-30 | -5290.53% |
| 2015-06-30 | -5572.34% |
| 2015-03-31 | -7403.16% |
| 2014-12-31 | -6102.11% |
| 2014-09-30 | -5394.74% |
| 2014-06-30 | -6624.47% |
| 2014-03-31 | -9271.58% |
| 2013-12-31 | -6856.84% |
| 2013-09-30 | -4630.53% |
| 2013-06-30 | -7131.58% |
| 2013-03-31 | -2895.36% |
| 2012-12-31 | -2429.74% |
| 2012-09-30 | -2082.05% |
| 2012-06-30 | -3809.90% |
| 2012-03-31 | -1955.22% |
| 2011-12-31 | -872.73% |
| 2011-09-30 | -2750.00% |
| 2011-06-30 | 345.85% |
| 2011-03-31 | 437.96% |
| 2008-09-30 | 373.31% |
| 2008-06-30 | -2949.45% |
| 2007-09-30 | 2595.60% |
| 2006-09-30 | -33329.12% |
| 2006-06-30 | -1911.15% |
